An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers
NCT00721448
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetics
Interventions
DRUG:
AZD6140
DRUG:
AZD6140
Sponsor
AstraZeneca